Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction
Therapy with epidermal growth factor receptor (EGFR) inhibitors is inevitably accompanied by the phenomena of dermatological toxicity. Being, on the one hand, a favorable prognostic factor for the effectiveness of anticancer therapy, these adverse events are one of the most frequent indications for...
Main Authors: | A. V. Michenko, L. S. Kruglova, E. A. Shatokhina, I. B. Kononenko, A. S. Polonskaya, D. V. Romanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/504 |
Similar Items
-
Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment
by: E. A. Shatokhina, et al.
Published: (2020-12-01) -
Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01) -
Adult acne a medical and psychological challenge of modern dermatology
by: Madalena Marzęda, et al.
Published: (2022-11-01) -
Butterfly rash with periodontitis: A diagnostic dilemma
by: Manvi Aggarwal, et al.
Published: (2012-01-01) -
Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01)